Mankind Pharma is set to enter India's semaglutide market soon. The drug's patent expires this month, opening doors for new players. Mankind Pharma plans to offer the medication at affordable prices. This move aims to improve patient access to this important therapy. The company sees a significant opportunity as semaglutide's use extends beyond diabetes to other health areas.
Darden Restaurants (NYSE:DRI – Get Free Report)‘s stock had its “buy” rating restated by analysts at BTIG Research in a research note issued on Friday,Benzinga reports. They currently have a $225.00 price target on the restaurant operator’s stock. BTIG Research’s target price points to a
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) had its target price lifted by Needham & Company LLC from $10.00 to $12.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price
Darden Restaurants (NYSE:DRI – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at BTIG Research in a report released on Friday,Benzinga reports. They currently have a $225.00 target price on the restaurant operator’s stock. BTIG Research’s target price would suggest a
Park Avenue Securities LLC boosted its stake in shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Free Report) by 2.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 831,843 shares of the company’s stock after acquiring an additional
